The market has been high on Castle Biosciences Inc (CSTL) stock recently. CSTL gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With CSTL Stock Today?
Castle Biosciences Inc (CSTL) stock has fallen -7.39% while the S&P 500 is up 0.21% as of 3:42 PM on Wednesday, Jan 13. CSTL is down -$5.84 from the previous closing price of $79.00 on volume of 306,840 shares. Over the past year the S&P 500 is higher by 15.85% while CSTL is up 120.30%. CSTL lost -$0.16 per share in the over the last 12 months.
More About Castle Biosciences Inc
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.